Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,487 | 710 | 99.6% |
| Education | $37.78 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,066 | 165 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $952.76 | 59 | $0 (2024) |
| Lilly USA, LLC | $804.08 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $755.09 | 43 | $0 (2024) |
| PFIZER INC. | $729.11 | 51 | $0 (2024) |
| Amgen Inc. | $723.90 | 56 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $536.18 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $412.81 | 25 | $0 (2023) |
| GlaxoSmithKline, LLC. | $364.24 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $318.30 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $924.73 | 52 | Lilly USA, LLC ($147.35) |
| 2023 | $1,093 | 72 | Novo Nordisk Inc ($222.29) |
| 2022 | $1,662 | 112 | Novo Nordisk Inc ($248.44) |
| 2021 | $2,022 | 132 | AstraZeneca Pharmaceuticals LP ($348.42) |
| 2020 | $1,493 | 105 | Novo Nordisk Inc ($469.32) |
| 2019 | $1,315 | 106 | Novo Nordisk Inc ($358.46) |
| 2018 | $958.62 | 69 | Novo Nordisk Inc ($244.06) |
| 2017 | $1,057 | 66 | Boehringer Ingelheim Pharmaceuticals, Inc. ($158.51) |
All Payment Transactions
714 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: DIABETES | ||||||
| 12/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Oncology | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: UROLOGY | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Diabetes Care | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Obesity | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: UROLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: Biological | ||||||
| 09/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: UROLOGY | ||||||
| 08/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Bone Health | ||||||
| 08/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: UROLOGY | ||||||
| 07/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: UROLOGY | ||||||
| 07/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Obesity | ||||||
| 07/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Oncology | ||||||
| 07/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $39.09 | General |
| Category: Endocrinology | ||||||
| 06/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,768 | 3,641 | $546,877 | $200,091 |
| 2022 | 16 | 1,819 | 3,903 | $420,751 | $200,774 |
| 2021 | 18 | 1,621 | 3,516 | $374,946 | $178,879 |
| 2020 | 18 | 1,920 | 3,990 | $420,417 | $172,722 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 536 | 1,584 | $370,081 | $119,912 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 290 | 290 | $75,493 | $34,536 | 45.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 57 | 74 | $20,380 | $14,551 | 71.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 414 | 923 | $25,803 | $7,742 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 121 | $19,613 | $6,692 | 34.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 27 | $5,400 | $4,060 | 75.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 44 | 49 | $3,920 | $3,525 | 89.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 48 | 87 | $8,892 | $3,258 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $5,278 | $2,156 | 40.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 19 | 66 | $2,747 | $973.24 | 35.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 34 | $850.00 | $833.00 | 98.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 15 | 15 | $1,800 | $592.82 | 32.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 54 | $2,376 | $471.57 | 19.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 15 | $1,230 | $455.85 | 37.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 49 | 73 | $1,070 | $248.93 | 23.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 13 | 13 | $143.00 | $57.60 | 40.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 41 | 174 | $1,740 | $14.27 | 0.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 20 | $60.00 | $13.65 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 588 | 1,785 | $291,955 | $142,997 | 49.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 245 | 245 | $50,545 | $29,724 | 58.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 115 | $12,904 | $6,611 | 51.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 28 | 31 | $10,370 | $6,423 | 61.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 19 | 20 | $4,000 | $3,080 | 77.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 443 | 960 | $26,765 | $2,846 | 10.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $8,019 | $2,693 | 33.6% |
About Dr. Harry Blackstone, DO
Dr. Harry Blackstone, DO is a Family Medicine healthcare provider based in Zephyrhills, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720016496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harry Blackstone, DO has received a total of $10,525 in payments from pharmaceutical and medical device companies, with $924.73 received in 2024. These payments were reported across 714 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($10,487).
As a Medicare-enrolled provider, Blackstone has provided services to 7,128 Medicare beneficiaries, totaling 15,050 services with total Medicare billing of $752,466. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Zephyrhills, FL
- Active Since 06/29/2006
- Last Updated 04/04/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1720016496
Products in Payments
- Ozempic (Drug) $1,201
- JARDIANCE (Drug) $740.05
- FARXIGA (Drug) $725.43
- XARELTO (Drug) $495.54
- TRULICITY (Drug) $328.77
- XIFAXAN (Drug) $317.12
- Vascepa (Drug) $316.74
- ENTRESTO (Drug) $286.10
- Aimovig (Biological) $280.66
- Otezla (Drug) $279.08
- TRELEGY ELLIPTA (Drug) $263.03
- Wegovy (Drug) $222.94
- Victoza (Drug) $204.50
- ELIQUIS (Drug) $202.51
- SOLIQUA 100/33 (Biological) $199.09
- GEMTESA (Drug) $195.35
- CHANTIX (Drug) $193.72
- NURTEC ODT (Drug) $177.11
- Kerendia (Drug) $167.95
- PREVNAR - 13 (Biological) $163.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Zephyrhills
Joseph Nystrom, Md, MD
Family Medicine — Payments: $12,782
Tamara Sealy, M.d, M.D
Family Medicine — Payments: $5,647
Kanchan Parasher, Md, MD
Family Medicine — Payments: $3,202
Dr. Farhan Rehman, M.d, M.D
Family Medicine — Payments: $2,455
Marcella Jones, Do, DO
Family Medicine — Payments: $2,340
Wilma Da Souza, Md, MD
Family Medicine — Payments: $1,447